The Drosophila melanogaster abi and the murine v-abl genes encode tyrosine protein kinases (TPKs) whose amino acid sequences are highly conserved. To assess functional conservation between the two gene products, we constructed Drosophila abl/v-abl-chimeric Abelson murine leukemia viruses. In these chimeric Abelson murine leukemia viruses, the TPK and carboxy-terminal regions of v-abl were replaced with the corresponding regions of D. melanogaster abl. The chimeric Abelson murine leukemia viruses were able to mediate morphological and oncogenic transformation of NIH 3T3 cells and were able to abrogate the interleukin-3 dependence of a lymphoid cell line. We also found that a virus that contained both TPK and carboxy-terminal Drosophila abl regions had no in vitro transforming activity for primary bone marrow cells and lacked the ability to induce tumors in susceptible mice. A virus that replaced only a portion of the v-abl TPK region with that ofDrosophila abl had low activity in in vitro bone marrow transformation and tumorigenesis assays. These results indicate that the transforming functions of abl TPKs are only partially conserved through evolution. These results also imply that the TPK region of v-abl is a major determinant of its efficient lymphoid cell-transforming activity.
The Drosophila abl gene encodes a protein of 1,521 amino acids which has tyrosine protein kinase (TPK) activity when expressed in bacteria (21) . Homozygous loss of function mutations in the Drosophila abl gene are usually lethal by the pharate adult stage of development (22) . Adult abl mutant flies are lethargic, show reduced viability and fecundity, and have roughened eyes (22) .
Analysis of the deduced amino acid sequence of the D. melanogaster abl gene-coding region shows that it shares significant identity with the v-abl oncogene and with the human and murine c-abl proto-oncogenes (21) . The proteins encoded by the v-abl, human and murine c-abl, and Drosophila abl genes show the most amino acid identity in the src-homology 2 (SH2) region (9, 36, 51, 61) (86% similarity and 78% identity) and in the TPK region (87% similarity and 77% identity). In addition, the Drosophila abl and murine * Corresponding author. and human c-abl genes are 60% identical in the src-homology 3 (SH3) (36, 61) region, which is located 5' to the SH2 region. Little sequence identity is seen in the carboxy portions of these molecules (28% similarity and 16% identity).
Overexpression of the normal c-abl gene does not result in cell transformation (26, 63) . Instead, oncogenic activation of the murine and human c-abl genes requires the presence of an amino-terminal myristoylation site and deletion of negative regulatory sequences 5' to the SH2 region (11, 26, 63) . The myristoylation site can be supplied by either c-abl sequences or M-MuLV gag sequences (11, 26, 63) .
In light of the high degree of amino acid sequence conservation between the D. melanogaster and v-abl proteins, it is of interest to determine whether evolutionary conservation of sequence implies functional conservation. Accordingly, we sought to determine whether (i) the transforming potential of the Drosophila abl gene can be activated by the same types of lesions shown to activate the transforming potentials of the murine and human c-abl genes; (ii) an activated Drosophila abl gene can substitute for the v-abl gene in A-MuLV; and (iii) the catalytic region of Drosophila abl, the TPK region, can substitute for the v-abl TPK region. Therefore, we constructed chimeric A-MuLV proviruses that substitute the TPK and carboxy-terminal regions of v-abl with the corresponding regions of Drosophila abl. We then analyzed the chimeric Drosophila abllv-abl proviruses for their fibroblast-and lymphoid cell-transforming activities.
MATERIALS AND METHODS
Cell lines and viruses. The NIH 3T3 cell line (27) used in transfection and virus infection experiments was cultured in Dulbecco modified Eagle medium supplemented with 3 to 5% calf serum (Hyclone, Logan, Utah). The interleukin 3 (IL-3)-dependent lymphoid cell line, FL5.12 (38) , was supplied by J. McCubrey, East Carolina University, Greenville, N.C., and was cultured in Iscove modified Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum (Hyclone) and 5% WEHI-3 conditioned medium as a CONSERVATION OF abl PROTEIN FUNCTION 2227 ATP-B Tyr-P . ' 8 8 I i.X ATP-B, ATP-binding site; SH2, src-homology 2 region; SH3, src-homology 3 region; TPK, tyrosine protein kinase region; Tyr-P, site of tyrosine autophosphorylation. 1, 2, 3, and p4Cl, DNA probes used for Southern hybridization studies.
source of IL-3 (25) . Primary bone marrow cells were collected from the tibias and femurs of 4-to 6-week-old BALB/c mice and were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum and 50 ,um ,-mercaptoethanol. All culture media were also supplemented with 100 U of penicillin, 100 ,ug of streptomycin, and 100 ,g of sodium pyruvate (GIBCO Laboratories, Grand Island, N.Y.) per ml. All cells were cultured in humidified incubators at 37°C with 5% CO2. NIH 3T3 cells were transfected by the calcium phosphate precipitation method as described before (16) . For virus production, 2 ,ug of construct DNA [A-MuLV(cD), A-MuLV(D), or A-MuLV(sd)] and 2 ,ug of pMOV-3 MMuLV proviral clone (19) DNA were cotransfected into NIH 3T3 cells. Titers of virus stocks derived from morphologically transformed cell lines were determined by focus formation on NIH 3T3 cells (53) and by UV-XC plaque formation (50) . FL5.12 cells were infected with virus and assayed for factor abrogation as described previously (37) . Twentyfour hours after infection, 106 cells were exposed to 4,000 rads in a 137Cs irradiator (J. L. Shepard and Associates, Glendale, Calif.) and plated as infectious centers as described before (37) . Infection of bone marrow cells was performed in liquid culture (16, 48) . Following infection, the cells were plated in either 96-well microdilution plates (Falcon; Becton Dickinson Labware, Lincoln Park, N.J.) at a density of 5 x 105 cells per ml (mass culture assay) (48) or 0.35% agarose-containing medium at a density of 2 x 106 cells per 60-mm dish (Falcon; Becton-Dickinson Labware) over a layer of 0.7% agarose-containing medium (agarose transformation assay), as described before (16, 47) .
Constructs and DNA analysis. The A-MuLV(cD) construct ( Fig. 1 ) was prepared by inserting the 5,297-base-pair (bp) NotI-BglII fragment of a Drosophila abl gene cDNA (21) into an EagI-Bglll-cleaved A-MuLV proviral clone, pABpro (16 DNA preparation and Southern blotting. High-molecularweight DNA was isolated from cell lines and tumors as described before (16, 17) . A 10-,ug amount of DNA was cleaved to completion with restriction endonucleases under conditions supplied by the manufacturer (New England BioLabs). The DNA fragments were then resolved by electrophoresis through 0.7% agarose gels, transferred to nitrocellulose filters (Schleicher & Schuell, Keene, N.H.) (59) , and hybridized to random-primer-labeled probes (10 (Fig. 1) . The Drosophila abl-specific p4C1 probe has been described previously ( Fig. 1) (15, 29) . In vitro kinase assays were performed as described before (15, (32) . Gels (7.5 or 10% polyacrylamide-SDS) were run at constant current. After electrophoresis, gels used for resolving in vitro kinase assay products were routinely treated with 1 M KOH at 55°C for 1 h to remove phosphoserine and phosphothreonine residues (Wang, (Fig. 1) . The p4C1 probe detected a 6.7-kb XbaI fragment only in the DNA of the A-MuLV(D) cell line (Fig. 2, p4C1 panel, lane 2) .
Because the A-MuLV(sd) construct was expected to yield the same size XbaI fragment as the parent A-MuLV, Southern blot analysis with different restriction endonucleases and probes was performed on the DNA of an A-MuLV(sd)-transformed cell line. Hybridization of NcoI-cleaved AMuLV and A-MuLV(sd) cell line DNAs with probe 3 (Fig. 1 ) showed 1.2-and 1.4-kb fragments, respectively, as predicted (Fig. 3, probe 3 panel, lanes 2 and 3) . To confirm that Drosophila abl sequences were present in the 1.4-kb NcoI fragment from A-MuLV(sd) cells, the p4C1 probe was used in the Southern hybridization experiments. The 1.4-kb NcoI fragment was detected by the p4C1 probe only in A-MuLV(sd) cells (Fig. 3, p4C1 panel, lane 2) .
These analyses indicate that the A-MuLV(D) and AMuLV(sd) integrated proviruses had the expected structures, as depicted (Fig. 1) , and that these constructs did not undergo gross deletions or rearrangements upon transfection and transmission.
Expression (Fig. 4, lanes 5 to 8) . In addition, the M-MuLV-encoded gag precursor protein, pr659aB, was also synthesized by the A-MuLV(D) and A-MuLV(sd) cell lines (Fig. 4, lanes 5 to 8) .
Because activated abl proteins have the ability to phosphorylate themselves and exogenous substrates in immune precipitates (35, 42, 43, 54, 66) (Table 1) (7), and equivalent amounts of protein were immunoprecipitated with a-p15Sa9 antiserum. Immune complexes were washed and suspended in Mn2+-kinase reaction buffer containing 1 1±Ci of [y-32P]ATP. The reaction mixtures were incubated at 30°C for 15 min, after which the immune complexes were washed in kinase lysis buffer and suspended in Laemli sample buffer. Samples were electrophoresed through 7.5% polyacrylamide-SDS gels, and the gel was treated with 1 M KOH for 1 h at 55°C to remove phosphoserine and phosophothreonine residues. In vitro lymphoid cell-transforming activities of A-MuLV (D) and A-MuLV(sd) viruses. In addition to the ability to transform murine fibroblastoid cell lines morphologically and oncogenically, activated abl genes can effect the in vitro transformation of primary lymphoid cells (48) . v-abl is unique among the members of the src family of TPKs in its ability to efficiently transform primary lymphoid cells. We therefore assayed the A-MuLV(D) and A-MuLV(sd) viruses for their abilities to transform bone marrow lymphoid cells in the mass culture (48) and agarose colony (47) assays. Although we observed extensive colony formation following infection of bone marrow cells with A-MuLV, infection of bone marrow cells with A-MuLV(D) did not give rise to agarose colonies ( Table 2) . Infection of bone marrow cells with A-MuLV(sd) did give rise to agarose colonies, but with 25-fold-lower efficiency than A-MuLV ( Table 2) . As the agarose colony assay is perhaps the most stringent test of A-MuLV lymphoid cell-transforming ability, we also as- formed cultures ( Table 2 ). Proliferation of bone marrow cells infected with A-MuLV(sd) was observed for a period of 1 to 2 weeks, after which the cultures usually degenerated ( Table  2) (Table 3) , although with lower frequencies than A-MuLV. Southern blot analysis, using the p4C1 probe, of XbaI-cleaved DNAs of the IL-3-independent cell lines (Table 4 ). Southern blot analysis showed that none of these tumors contained Drosophila abl-hybridizing sequences and were most likely of M-MuLV helper virus origin. Therefore, the A-MuLV(D) virus did not induce tumors in susceptible mice. In contrast, 1 of 13 mice injected with the A-MuLV(sd) virus developed disease characterized by hind limb paralysis and enlarged lymph nodes and spleen 46 days after injection ( Table 4 ). The symptom of hind limb paralysis, coupled with enlarged lymph nodes and spleen, is characteristic of classical Abelson virus disease (45, 45) . Southern blot analysis, using the p4Cl probe, of DNAs from the tumor tissues (lymph node and spleen) of this animal showed the presence of the A-MuLV(sd)-specific 1.4-kb NcoI fragment in these DNAs (data not shown). Additional Southern blot analysis of XbaI-cleaved DNAs of the tissues showed that the Drosophila abl-hybridizing sequences were present on a genome size 5.8-kb fragment (data not shown). Therefore, A-MuLV(sd) could induce disease in mice, although with much less efficacy than A-MuLV.
DISCUSSION
To address the question of functional conservation among abl genes, we constructed Drosophila abllv-abl chimeric (15) .
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Our studies of the A-MuLV(cD) construct indicated that the normal Drosophila abl gene in the context of A-MuLV did not morphologically transform NIH 3T3 cells. Although we have no evidence that the abl(cd) protein was expressed, it is most likely that the A-MuLV(cD) construct failed to transform NIH 3T3 cells because its encoded protein was inactive due to the presence of amino-terminal negative regulatory elements (11, 26, 63) .
Replacement of sequences encoding the amino terminus and SH3 region of Drosophila abl with A-MuLV gag sequences generated the chimeric A-MuLV, A-MuLV(D). Transfection of this proviral construct into NIH 3T3 cells resulted in the morphological transformation of these cells. These results indicate that the transforming potential of the Drosophila abl gene could be activated by the addition of M-MuLV gag sequences and by the removal of negative regulatory sequences 5' to the SH2 region. These changes are similar to those which have been shown to activate the transforming potential of other c-abl genes (11, 26, 63) . Our studies of the A-MuLV(D) chimera showed that it could also abrogate the IL-3 dependence of a lymphoid cell line. However, the v-abl primary lymphoid cell transformation function was not conserved in A-MuLV(D) as this virus was unable to effect in vitro bone marrow transformation. The leukemogenic activity of A-MuLV was also not conserved in A-MuLV(D) as this virus did not induce tumors in the most susceptible host, the weanling BALB/c mouse (45, 46) . Thus, Drosophila abl could only partially substitute for v-abl in A-MuLV.
The inability of A-MuLV(D) to transform primary lymphoid cells can be ascribed to several factors. First, the v-abl and Drosophila abl gene sequences show considerable divergence in the regions encoding the carboxy-terminal portions of the proteins. It may be that these differences give rise to altered substrate specificity, altered kinase activity, or altered protein stability. Indeed, the work of several investigators has suggested that regions downstream of the kinase region of v-abl can act to enhance the in vitro lymphoid cell-transforming and tumorigenic abilities of AMuLV (49) .
Second, examination of the TPK regions of Drosophila abl and v-abl reveals several nonconservative amino acid differences (Fig. 6 ). In particular, the v-abl gene sequenced here, as well as another v-abl gene (P. Jackson and D. Baltimore, unpublished results), encodes a valine residue at position 522 immediately downstream of the major site of tyrosine autophosphorylation (Fig. 6) . In contrast, the Drosophila abl and human c-abl genes encode a phenylalanine residue at the corresponding position (Fig. 6 ). This change from phenylalanine to valine may contribute to the transforming activity of the v-abl protein.
To (Fig. 6) . Therefore, it will be possible to use smaller substitutions and in vitro mutagenesis to define more precisely the determinants of lymphoid transformation of v-abl. These experiments are in progress.
